KROS
Closed
Keros Therapeutics inc
13.34
-0.01 (-0.07%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 13.35
Day's Range: 13.3 - 13.64
Send
sign up or login to leave a comment!
When Written:
40.14
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on the development of novel therapeutics for the treatment of rare diseases. The company's lead product candidate, KER-050, is a first-in-class, engineered ligand trap that is designed to address the underlying cause of anemia in patients with myelodysplastic syndromes and myelofibrosis. Keros Therapeutics is also developing a pipeline of other product candidates that target various disease pathways, including those involved in fibrosis and cancer. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








